Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 18Genitourinary 14Sarcoma 12Gastrointestinal 11Dermatologic 5Other hematologic neoplasm 4Lymphoid 4Thoracic 3Myeloid 3Breast 3Plasma cell 2Other solid neoplasm 2Head & Neck 2NET 1Gynecologic 1Endocrine 1Classical hematology 1

Conditions

Ovarian Neoplasms 814Uterine Cervical Neoplasms 549Endometrial Neoplasms 467Breast Neoplasms 227Fallopian Tube Neoplasms 202Colorectal Neoplasms 182Carcinoma, Non-Small-Cell Lung 163Neoplasms 140Stomach Neoplasms 128Pancreatic Neoplasms 120Prostatic Neoplasms 109Melanoma 108Neoplasm Metastasis 107Lung Neoplasms 105Carcinoma, Ovarian Epithelial 94Triple Negative Breast Neoplasms 92Squamous Cell Carcinoma of Head and Neck 82Esophageal Neoplasms 78Head and Neck Neoplasms 77Carcinoma, Renal Cell 76Urinary Bladder Neoplasms 75Uterine Neoplasms 67Vulvar Neoplasms 66Colonic Neoplasms 60Uterine Cervical Dysplasia 59Peritoneal Neoplasms 59Carcinoma, Hepatocellular 59Sarcoma 53Carcinoma, Transitional Cell 49Papillomavirus Infections 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms, Germ Cell and Embryonal × Gynecologic × 1 year × Clear all
NCT06276491 2026-03-17

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Xencor, Inc.

Phase 1 Recruiting
282 enrolled
GenitourinaryGynecologic

Testicular Germ Cell Tumor, Neoplasms, Germ Cell and Embryonal, Ovarian Neoplasms, Testicular Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡